By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Acneowin for boys

CheckCompareThe price unknown
Can't order it
  1. Pharmacological Group
  2. Pharmacological action
  3. Method of drug use and dosage
  4. Contraindications
  5. Storage conditions
  6. Expiration date
  7. Manufacturers of the drug
Acneowin for boys

Pharmacological Group

Dietary supplements - bee products

Pharmacological action

 Источник катехинов, кофеина, дополнительный источник цинка, содержит сапонины и метилсульфанилметан.

Method of drug use and dosage

 Юношам (от 14 лет и старше) по 1 капс. 3 раза в день во время еды. Продолжительность приема - 4-6 нед. При необходимости прием можно повторить. Возможны повторные приемы в течение года.

Contraindications

 Индивидуальная непереносимость компонентов, бессонница, прием в вечернее время.

Storage conditions

 В сухом, защищенном от прямых солнечных лучей месте, при температуре не выше 25 °C.
 Хранить в недоступном для детей месте.

Expiration date

 2 года.
 Не применять по истечении срока годности, указанного на упаковке.

Manufacturers (or distributors) of the drug

ГНЦ ПМ ФАРМА
Народные Промыслы
42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.